Canadian Urological Association best practice report: Diagnosis and management of nocturia

Affiliations

¹ Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
² Division of Urology, CIUSSS-Capitale Nationale Université Laval, Quebec, QC, Canada.
³ Department of Urology, Dalhousie University, Halifax, NS, Canada.
⁴ Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
⁵ Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada.
⁶ Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
⁷ Division of Urology, Department of Surgery, Western University, London, ON, Canada.
⁸ Department of Surgery, University of Calgary, Calgary, AB, Canada.
⁹ vesia (Alberta Bladder Centre), Calgary, AB, Canada.
¹⁰ Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.

PMID: 35819914
PMCID: PMC9328849
DOI: 10.5489/cuaj.7970

Canadian Urological Association best practice report: Diagnosis and management of nocturia

Laura N Nguyen et al. Can Urol Assoc J. 2022 Jul.

. 2022 Jul;16(7):E336-E349.

doi: 10.5489/cuaj.7970.

Authors

Affiliations

¹ Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
² Division of Urology, CIUSSS-Capitale Nationale Université Laval, Quebec, QC, Canada.
³ Department of Urology, Dalhousie University, Halifax, NS, Canada.
⁴ Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
⁵ Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada.
⁶ Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
⁷ Division of Urology, Department of Surgery, Western University, London, ON, Canada.
⁸ Department of Surgery, University of Calgary, Calgary, AB, Canada.
⁹ vesia (Alberta Bladder Centre), Calgary, AB, Canada.
¹⁰ Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.

PMID: 35819914
PMCID: PMC9328849
DOI: 10.5489/cuaj.7970

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Nguyen has been a speaker for Astellas and Pfizer. Dr. Nadeau has been an advisory board member for Allergan, Astellas, Boston Scientific, Ferring, and Pfizer; has been a speaker for Allergan, Astellas, Boston Scientific, Ferring, Laborie, Pfizer, Red Leaf Medical, and Searchlight Pharma; has received payment from Allergan, Boston Scientific, Red Leaf Medical, and Searchlight Pharma (preceptorships); and has received a research grant from Pfizer. Dr. Cox has been an advisory board member for Astellas, Pfizer, and TEVA; a speaker for Astellas and Pfizer; and is the site lead of a clinical trial supported by Aquinox. Dr. Campeau has been an advisory board member for Allergan, Astellas, and Coloplast; and has been a speaker for Astellas and Coloplast. Dr. Carlson has been an advisory board member for and received honoraria from Abbvie. The remaining authors do not report any competing personal or financial interests related to this work.

Figures

**Figure 1**
Prevalence of nocturia **(A)** one or more times per night; and **(B)** two or more times per night in Canadian adults, by age and sex.

**Figure 2**
Initial workup of patients presenting with nocturia. ESS: Epworth Sleepiness Scale; ICIQ-N: International Consultation on Incontinence Questionnaire-Nocturia; N-QoL: Nocturia Quality of Life Questionnaire; NI-Diary: Nocturia Impact Diary; OSA: obstructive sleep apnea; PSA: prostate-specific antigen; TANGO SF: Targeting the Individual’s Aetiology of Nocturia to Guide Outcomes Short Form.

**Figure 3**
Multimodal approach to management of nocturia, organized by disease domains with subsequent pathways for treatment and consideration of specialist referral. Note that nocturia is often multifactorial and requires workup and management across multiple domains to achieve patient treatment goals. Clinical specialties listed are not exhaustive and may vary by region. 5ARI: 5-alpha-reductase inhibitors; BOO: bladder outlet obstruction; CPAP: continuous positive airway pressure; OAB: overactive bladder; OSA: obstructive sleep apnea; PCP: primary care practitioner.

See this image and copyright information in PMC

References

1. Van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int. 2002;90(Suppl3):11–5. doi: 10.1046/j.1464-410X.90.s3.3.x. - DOI - PubMed
1. Tikkinen KA, Johnson TM, 2nd, Tammela TL, et al. Nocturia frequency, bother, and quality of life: How often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–96. doi: 10.1016/j.eururo.2009.03.080. - DOI - PubMed
1. Kupelian V, Rosen RC, Link CL, et al. Association of urological symptoms and chronic illness in men and women: Contributions of symptom severity and duration — results from the BACH Survey. J Urol. 2009;181:694–700. doi: 10.1016/j.juro.2008.10.039. - DOI - PMC - PubMed
1. Kupelian V, Fitzgerald MP, Kaplan SA, et al. Association of nocturia and mortality: Results from the Third National Health and Nutrition Examination Survey. J Urol. 2011;185:571–7. doi: 10.1016/j.juro.2010.09.108. - DOI - PubMed
1. Akerla J, Pesonen JS, Poyhonen A, et al. Lower urinary tract symptoms and mortality among Finnish men: The roles of symptom severity and bother. J Urol. 2022;207:1285–94. doi: 10.1097/JU.0000000000002450. - DOI - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Canadian Urological Association best practice report: Diagnosis and management of nocturia

Affiliations

Canadian Urological Association best practice report: Diagnosis and management of nocturia

Authors

Affiliations

Conflict of interest statement

Figures

References

LinkOut - more resources

Full Text Sources